Regulation & Compliance

As new EU laws on AI and sustainability take full effect, over 250 compliance leaders will meet in Berlin to forge strategies for navigating the risks.

Computational chemistry firm Evogene adds world-renowned experts to guide its ChemPass AI™, aiming to accelerate drug and ag-chemical innovation.

A new deal pairs Inturai's AI sensing platform with a firm of elite special forces veterans, aiming to revolutionize intelligence for North American forces.

Following a massive corruption scandal in Toronto, Ontario's Inspector General has launched a province-wide probe into police integrity and accountability.

Peijia Medical submits its innovative GeminiOne heart valve repair system for EU approval, signaling a new challenge to established players in the market.

After a second bankruptcy filing in five years, the 25-year-old fashion chain is closing for good, sparking huge sales and questions about its collapse.

As Quebec debates its constitutional future, a key group urges lawmakers to see linguistic duality as an economic asset, not a political liability.

A new class action lawsuit alleges Paysafe misled investors about major client risks and industry vulnerabilities, leading to a massive 27% stock drop.

A vague error code on millions of TRUE METRIX glucose meters led to delayed care. The company is now issuing a critical warning to prevent further harm.

Chinese brand CHANDO presented a decade of research at IMCAS, revealing a new epigenetic mechanism that could revolutionize brightening for Asian skin.

A new coalition of 40 agricultural groups is launching a major push to renew the USMCA, citing a new economic study ahead of a high-stakes 2026 review.

RegEd's landmark achievement in data processing highlights a critical shift in financial services, where automated RegTech is no longer a luxury but a necessity.

The medical device giant posts 6% Q1 growth but faces major challenges from US reimbursement changes and a China recall, banking on a new acquisition.

The high-tech wheel maker's stock plummets 65% as it fails to meet listing rules, signaling deep financial and operational distress for the company.

Republic Technologies taps Canadian Solar’s CFO, signaling a strategic move to blend traditional financial discipline with Web3 infrastructure development.

With a massive Bitcoin injection, TIRX aims for stablecoin dominance in ASEAN, but faces a maze of regulatory hurdles and unproven technical claims.

A European company with Big Pharma roots brings its natural allergy aid, SnizIQ, to California, tapping into a growing demand for alternatives.

EMD Serono and the Trump Administration launch a new program offering massive discounts on IVF drugs, bringing hope to millions of aspiring parents.

Marex's acquisition of Webb Traders signals a major push into automated equity derivatives, aiming to internalize hedging and challenge market norms.

Aucta Pharma launches two rare disease drugs, PYQUVI and ZELVYSIA, betting on a 'branded-generic' model to navigate highly competitive markets.